Guardant Health And ConcertAI Set Commercial Goals For Cancer Therapy Data-Sharing Deal

Partnership Brings Together Cancer Patient Clinical And Genomic Datasets

Guardant Health seeks to bring genomic cancer disease data into a clinical context in a new collaboration with ConcertAI aimed at designing cancer therapeutics and clinical trials, Amar Das, VP of real world evidence at Guardant Health, told Medtech Insight.

Data analytics
(Shutterstock)

Cancer diagnostics innovator Guardant Health and ConcertAI, a provider in cancer real-world data and AI-driven solutions, will share and integrate cancer patient data as part of a new collaboration announced on January 16.

More from Diagnostics

More from Business